These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 3632000

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Toxic epidermal necrolysis (drug-induced Lyell's syndrome). I. Clinical features and differential diagnosis].
    Konstantinow A, Mühlbauer W, Balda BR, Ring J.
    Dtsch Med Wochenschr; 2001 Feb 09; 126(6):141-4. PubMed ID: 11233882
    [No Abstract] [Full Text] [Related]

  • 4. [Toxic epidermal necrolysis and Stevens-Johnson syndrome].
    Roujeau JC.
    Rev Prat; 2007 Jun 15; 57(11):1165-70. PubMed ID: 17691257
    [Abstract] [Full Text] [Related]

  • 5. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
    Chang YS, Huang FC, Tseng SH, Hsu CK, Ho CL, Sheu HM.
    Cornea; 2007 Feb 15; 26(2):123-9. PubMed ID: 17251797
    [Abstract] [Full Text] [Related]

  • 6. [Ocular sequelae and sicca syndrome following Lyell's syndrome].
    Roujeau JC, Phlippoteau C, Koso M, Wechsler J, Binaghi M, Revuz J, Touraine R.
    Ann Dermatol Venereol; 1985 Feb 15; 112(11):883-8. PubMed ID: 3879142
    [Abstract] [Full Text] [Related]

  • 7. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
    Morales ME, Purdue GF, Verity SM, Arnoldo BD, Blomquist PH.
    Am J Ophthalmol; 2010 Oct 15; 150(4):505-510.e1. PubMed ID: 20619392
    [Abstract] [Full Text] [Related]

  • 8. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
    Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schröder W, Roujeau JC, SCAR Study Group. Severe Cutaneous Adverse Reactions.
    Arch Dermatol; 2002 Aug 15; 138(8):1019-24. PubMed ID: 12164739
    [Abstract] [Full Text] [Related]

  • 9. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Harr T, French LE.
    Chem Immunol Allergy; 2012 Aug 15; 97():149-66. PubMed ID: 22613860
    [Abstract] [Full Text] [Related]

  • 10. Staphylococcal scalded skin syndrome in an immunocompetent adult, clinically mimicking toxic epidermal necrolysis.
    Tseng HC, Wu WM, Lin SH.
    J Dermatol; 2014 Sep 15; 41(9):853-4. PubMed ID: 25041582
    [No Abstract] [Full Text] [Related]

  • 11. Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment.
    Schwartz RA, McDonough PH, Lee BW.
    J Am Acad Dermatol; 2013 Aug 15; 69(2):187.e1-16; quiz 203-4. PubMed ID: 23866879
    [Abstract] [Full Text] [Related]

  • 12. The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Mockenhaupt M.
    Expert Rev Clin Immunol; 2011 Nov 15; 7(6):803-13; quiz 814-5. PubMed ID: 22014021
    [Abstract] [Full Text] [Related]

  • 13. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.
    Yamane Y, Matsukura S, Watanabe Y, Yamaguchi Y, Nakamura K, Kambara T, Ikezawa Z, Aihara M.
    Allergol Int; 2016 Jan 15; 65(1):74-81. PubMed ID: 26666483
    [Abstract] [Full Text] [Related]

  • 14. Toxic epidermal necrolysis--a premature requiem?
    Lancet; 1990 Jul 28; 336(8709):218-9. PubMed ID: 1973776
    [No Abstract] [Full Text] [Related]

  • 15. Drug-induced toxic epidermal necrolysis. I. An overview.
    Lyell A.
    Clin Dermatol; 1993 Jul 28; 11(4):491-2. PubMed ID: 8124637
    [No Abstract] [Full Text] [Related]

  • 16. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
    Mohanty S, Das A, Ghosh A, Sil A, Gharami RC, Bandyopadhyay D, Das NK.
    Indian J Dermatol Venereol Leprol; 2017 Jul 28; 83(3):312-316. PubMed ID: 28366923
    [Abstract] [Full Text] [Related]

  • 17. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.
    Nizamoglu M, Ward JA, Frew Q, Gerrish H, Martin N, Shaw A, Barnes D, Shelly O, Philp B, El-Muttardi N, Dziewulski P.
    Burns; 2018 May 28; 44(3):603-611. PubMed ID: 29029855
    [Abstract] [Full Text] [Related]

  • 18. Toxic epidermal necrolysis in Stevens--Johnson syndrome.
    Assaad D, From L, Ricciatti D, Shapero H.
    Can Med Assoc J; 1978 Jan 21; 118(2):154-6. PubMed ID: 757383
    [Abstract] [Full Text] [Related]

  • 19. Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome/toxic epidermal necrolysis by immunohistopathological features.
    Cho YT, Lin JW, Chen YC, Chang CY, Hsiao CH, Chung WH, Chu CY.
    J Am Acad Dermatol; 2014 Mar 21; 70(3):539-48. PubMed ID: 24388722
    [Abstract] [Full Text] [Related]

  • 20. Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation.
    de Prost N, Mekontso-Dessap A, Valeyrie-Allanore L, Van Nhieu JT, Duong TA, Chosidow O, Wolkenstein P, Brun-Buisson C, Maître B.
    Crit Care Med; 2014 Jan 21; 42(1):118-28. PubMed ID: 23989174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.